Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD).

Kukuła K, Chojnowska L, Dąbrowski M, Witkowski A, Chmielak Z, Skwarek M, Kądziela J, Teresińska A, Małecki M, Janik P, Lewandowski Z, Kłopotowski M, Wnuk J, Rużyłło W.

Am Heart J. 2011 Mar;161(3):581-9. doi: 10.1016/j.ahj.2010.11.023. Epub 2011 Jan 31.

PMID:
21392615
2.

[Analysis of treatment results of boys referred to outpatient paediatric surgery centre with recognition of phimosis].

Zwolińska E, Janik P, Ratajczak D.

Wiad Lek. 2008;61(7-9):195-200. Polish.

PMID:
19172831
3.

[Adeno-associated viruses (AAV)].

Małecki M, Woźniak A, Janik P.

Postepy Biochem. 2008;54(1):57-63. Polish.

PMID:
18610582
4.

Variant t(2;11)(p11.2;q13) without IGK involvement in a case of mantle cell lymphoma.

Woroniecka R, Grygalewicz B, Pienkowska-Grela B, Rymkiewicz G, Konecki R, Swoboda P, Janik P.

Cancer Genet Cytogenet. 2007 Jun;175(2):154-8.

PMID:
17556072
5.

Unusual cyclin D1 positive marginal zone lymphoma of mediastinum.

Rymkiewicz G, Ptaszyński K, Walewski J, Błachnio K, Swoboda P, Gos M, Paszkiewicz-Kozik E, Woroniecka R, Pieńkowska-Grela B, Czarnocka M, Janik P.

Med Oncol. 2006;23(3):423-8.

PMID:
17018901
6.

Vascular endothelial growth factor and soluble FLT-1 receptor interactions and biological implications.

Malecki M, Trembacz H, Szaniawska B, Przybyszewska M, Janik P.

Oncol Rep. 2005 Dec;14(6):1565-9.

PMID:
16273257
7.

"Bystander effect" induced by photodynamically or heat-injured ovarian carcinoma cells (OVP10) in vitro.

Dabrowska A, Goś M, Janik P.

Med Sci Monit. 2005 Sep;11(9):BR316-24. Epub 2005 Aug 26.

PMID:
16127353
8.

Mantle cell lymphoma presenting with paraproteinemia.

Rymkiewicz G, Gos M, Błachnio K, Woroniecka R, Swoboda P, Pieńkowska-Grela B, Kulińska M, Borawska A, Janik P, Walewski J.

Med Oncol. 2005;22(3):319-23.

PMID:
16110143
9.

In vivo study of angiogenic plasmid preparations--the bicistronic plasmid as a new type of drug for vascular diseases.

Małecki M, Swoboda P, Jastrzebski Z, Janik P.

Acta Pol Pharm. 2004 Jul-Aug;61(4):289-95.

10.

[Gene therapy with phVEGF165 plasmid--preliminary report].

Kołsut P, Małecki M, Firek B, Teresińska A, Janik P, Religa Z.

Kardiol Pol. 2004 Feb;60 Suppl 1:I-82-9. Polish. No abstract available.

PMID:
15247953
11.

Gene therapy of coronary artery disease with phvegf165--early outcome.

Kołsut P, Małecki M, Zelazny P, Teresińska A, Firek B, Janik P, Religa Z.

Kardiol Pol. 2003 Nov;59(11):373-84. English, Polish.

PMID:
14668888
12.

Role of v-Raf and truncated form RAF1 in the induction of vascular endothelial growth factor and vascularization.

Malecki M, Seneta M, Miloszewska J, Trembacz H, Przybyszewska M, Janik P.

Oncol Rep. 2004 Jan;11(1):161-5.

PMID:
14654920
13.

Cytostatic and cytotoxic effects of alkylglycerols (Ecomer).

Krotkiewski M, Przybyszewska M, Janik P.

Med Sci Monit. 2003 Nov;9(11):PI131-5.

PMID:
14586289
14.
15.

The role of focal adhesion kinase in the emigration of cells from confluent cultures.

Trembacz H, Miłoszewska J, Szaniawska B, Małecki M, Przybyszewska M, Skorski T, Janik P.

Cell Mol Biol Lett. 2002;7(4):1047-57.

PMID:
12511971
16.

The Role of Focal Adhesion Kinase (FAK) in Contact Inhibition.

Miloszewska J, Trembacz H, Malecki M, Janik P.

Cell Mol Biol Lett. 2001;6(2):220. No abstract available.

PMID:
11544672

Supplemental Content

Loading ...
Support Center